Late-Breaking Clinical Trials

Submission Deadline: Wed., Dec. 18 at 1:00 p.m. ET

Submission Instructions

Policies and Procedures

The submission process for Late-Breaking Clinical Trials is now closed. Plan to join us in Chicago for the presentation of cutting-edge science!

LBCT submissions were accepted in the following categories:

  • Major Study
  • Smaller Study/Randomized Clinical Trial
  • Multi-center Observational Study or Registry
  • Secondary Analysis of Major Clinical Trial
  • Other

Accepted Late-Breaking Clinical Trial submissions will be presented in the ACC.20/WCC Main Tent during one of five LBCT sessions. Three LBCT sessions will be co-sponsored by the Journal of the American College of Cardiology (JACC), the Journal of the American Medical Association (JAMA) and the New England Journal of Medicine (NEJM). Each accepted submission will be considered for JACC Rapid Review and publication in JACC, JAMA and NEJM. In addition, each LBCT session will be followed by a press conference with top media outlets.

ADVERTISEMENT
Have a question about ACC.20/WCC?
Ask Artie, our show expert chatbot.
ACC Logo
ACC.20/WCC on Social Media:
      
2019 American College of Cardiology Foundation. Visit ACC.org
Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Cookie Policy Contact Us